CoChat

Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling

Open access
Zhang, Yuan, Li, Rui, Meng, Yan, Li, Shiwu, Donelan, William, Zhao, Yan, Qi, Lei, Zhang, Mingxiang, Wang, Xingli, Cui, Taixing, Yang, Li-Jun, Tang, Dongqi · 2014 · Diabetes

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

The number and activity of brown adipocytes are linked to the ability of mammals to resist body fat accumulation. In some conditions, certain white adipose tissue (WAT) depots are readily convertible to a ‘‘brown-like’’ state, which is associated with weight loss. Irisin, a newly identified hormone, is secreted by skeletal muscles into circulation and promotes WAT “browning” with unknown mechanisms. In the current study, we demonstrated in mice that recombinant irisin decreased the body weight and improved glucose homeostasis. We further showed that irisin upregulated uncoupling protein-1 (UCP-1; a regulator of thermogenic capability of brown fat) expression. This effect was possibly mediated by irisin-induced phosphorylation of the p38 mitogen-activated protein kinase (p38 MAPK) and extracellular signal–related kinase (ERK) signaling pathways. Inhibition of the p38 MAPK by SB203580 and ERK by U0126 abolished the upregulatory effect of irisin on UCP-1. In addition, irisin also promoted the expression of betatrophin, another newly identified hormone that promotes pancreatic β-cell proliferation and improves glucose tolerance. In summary, our data suggest that irisin can potentially prevent obesity and associated type 2 diabetes by stimulating expression of WAT browning-specific genes via the p38 MAPK and ERK pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db13-1106

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Expression of r-irisin and glycosylation of r-irisin. A: Culture supernatants (40 μL) from the S1 clone fermentation were collected daily up to day 6. The human r-irisin protein in the supernatants was visualized by Coomassie blue staining and confirmed by Western blotting with anti-irisin antibodies (B). C: PNGase-F treatment of r-irisin removed glycosylation and confirmed by Western blot. D: SDS-PAGE analysis of wild-type (WT) and mutant forms of irisin (N7H and N52H) expression and deglycosylation by PNGase-F treatment. (A high-quality color representation of this figure is available in the online issue.)
Figure 1 Expression of r-irisin and glycosylation of r-irisin. A: Culture supernatants (40 μL) from the S1 clone fermentation were collected daily up to day 6. The human r-irisin protein in the supernatants was visualized by Coomassie blue staining and confirmed by Western blotting with anti-irisin antibodies (B). C: PNGase-F treatment of r-irisin removed glycosylation and confirmed by Western blot. D: SDS-PAGE analysis of wild-type (WT) and mutant forms of irisin (N7H and N52H) expression and deglycosylation by PNGase-F treatment. (A high-quality color representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
Figure 2 Effects of r-irisin and mutants on the expression of brown adipocyte–specific genes in 3T3-L1–derived adipocytes. 3T3-L1–derived adipocytes were treated with r-irisin (20 nmol/L) as described in research design and methods. A: Expression of brown/beige adipocyte marker, betatrophin, and white adipocyte marker (aP2 and adipoq) genes were measured by RT-qPCR. *P < 0.05; **P < 0.01 vs. untreated. B: Western blot and densitometric analysis for UCP-1 protein in cells with indicated treatments. **P < 0.01. C: Oil Red O staining for lipid droplets confirmed adipocyte differentiation (top) and quantification of UCP-1–positive cells in ICC using Imagepro Plus software (bottom). Data were expressed as mean ± SE of three independent experiments. **P < 0.01 vs. adipocytes without irisin. D: Biological function of mutant irisin. 3T3-L1–derived adipocytes were treated as indicated, and expression levels of UCP-1 and PGC-1α genes were measured by qPCR. *P < 0.05; **P < 0.01 vs. control. E: UCP-1 protein expression was detected by Western blotting and measured by densitometry. N7H refers to mutated irisin after mutating asparagine 7 to histidine. N52H refers to mutated irisin after mutating asparagine 52 to histidine. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (A high-quality color representation of this figure is available in the online issue.)
Figure 2 Effects of r-irisin and mutants on the expression of brown adipocyte–specific genes in 3T3-L1–derived adipocytes. 3T3-L1–derived adipocytes were treated with r-irisin (20 nmol/L) as described in research design and methods. A: Expression of brown/beige adipocyte marker, betatrophin, and white adipocyte marker (aP2 and adipoq) genes were measured by RT-qPCR. *P < 0.05; **P < 0.01 vs. untreated. B: Western blot and densitometric analysis for UCP-1 protein in cells with indicated treatments. **P < 0.01. C: Oil Red O staining for lipid droplets confirmed adipocyte differentiation (top) and quantification of UCP-1–positive cells in ICC using Imagepro Plus software (bottom). Data were expressed as mean ± SE of three independent experiments. **P < 0.01 vs. adipocytes without irisin. D: Biological function of mutant irisin. 3T3-L1–derived adipocytes were treated as indicated, and expression levels of UCP-1 and PGC-1α genes were measured by qPCR. *P < 0.05; **P < 0.01 vs. control. E: UCP-1 protein expression was detected by Western blotting and measured by densitometry. N7H refers to mutated irisin after mutating asparagine 7 to histidine. N52H refers to mutated irisin after mutating asparagine 52 to histidine. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (A high-quality color representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
Figure 3 Browning effect of r-irisin on rat primary adipocytes. Primary rat adipocytes were treated with r-irisin at indicated concentrations for 6 h. A: The expression levels of UCP-1 and PGC-1α genes were measured by RT-qPCR. B: UCP-1 protein expression was measured by Western blotting and quantified by densitometry. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. *P < 0.05; **P < 0.01 vs. untreated.
Figure 3 Browning effect of r-irisin on rat primary adipocytes. Primary rat adipocytes were treated with r-irisin at indicated concentrations for 6 h. A: The expression levels of UCP-1 and PGC-1α genes were measured by RT-qPCR. B: UCP-1 protein expression was measured by Western blotting and quantified by densitometry. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. *P < 0.05; **P < 0.01 vs. untreated.CC BY-NC-ND · PubMed Central
Figure 4 Irisin stimulates adipocyte browning via p38/ERK pathways. Primary rat adipocytes and 3T3-L1–derived adipocytes were treated with PBS (control [con]) or r-irisin (20 nmol/L) at indicated time points. Phosphorylated and total p38 and ERK1/2 in cell lysates were analyzed by Western blotting with anti–P-p38 or anti–P-ERK antibodies. Expression levels of P-p38 and total p38 protein in primary adipocytes (A) and 3T3-L1 adipocytes (B) were measured by corresponding densitometric quantification. Expression levels of P-ERK and total ERK in primary (C) and 3T3-L1–derived (D) adipocytes were measured with corresponding densitometric quantification. Densitometric analysis of the related bands was expressed as relative optical density of the bands, corrected using respective total protein as a loading control and normalized against the untreated control. Data were expressed as mean ± SE of three independent experiments. *P < 0.05; **P < 0.01 vs. control. E: 3T3-L1–derived adipocytes were pretreated for 30 min with p38 inhibitor SB023580 or ERK inhibitor U0126 at indicated concentrations followed by r-irisin treatment. Western blotting detected phosphorylated and total p38 and ERK proteins.
Figure 4 Irisin stimulates adipocyte browning via p38/ERK pathways. Primary rat adipocytes and 3T3-L1–derived adipocytes were treated with PBS (control [con]) or r-irisin (20 nmol/L) at indicated time points. Phosphorylated and total p38 and ERK1/2 in cell lysates were analyzed by Western blotting with anti–P-p38 or anti–P-ERK antibodies. Expression levels of P-p38 and total p38 protein in primary adipocytes (A) and 3T3-L1 adipocytes (B) were measured by corresponding densitometric quantification. Expression levels of P-ERK and total ERK in primary (C) and 3T3-L1–derived (D) adipocytes were measured with corresponding densitometric quantification. Densitometric analysis of the related bands was expressed as relative optical density of the bands, corrected using respective total protein as a loading control and normalized against the untreated control. Data were expressed as mean ± SE of three independent experiments. *P < 0.05; **P < 0.01 vs. control. E: 3T3-L1–derived adipocytes were pretreated for 30 min with p38 inhibitor SB023580 or ERK inhibitor U0126 at indicated concentrations followed by r-irisin treatment. Western blotting detected phosphorylated and total p38 and ERK proteins.CC BY-NC-ND · PubMed Central
Figure 5 Inhibiting p38 MAPK and ERK prevents the expression of UCP-1. Primary rat (A and C) and 3T3-L1 (B and D) adipocytes were pretreated with SB (10 μmol/L) or U0 (10 μmol/L) and both for 30 min, and then r-irisin (20 nmol/L) was supplemented for an additional 4 days. UCP-1 expression at mRNA level by qPCR analysis (A and B) and at protein levels by Western blotting (C and D) was examined. For C and D, the bar graph represents the ratio of UCP-1/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and is normalized against the control group. Data are expressed as mean ± SE of three independent experiments. *P < 0.05; **P < 0.01 vs. control group; ++P < 0.01; +P < 0.05 vs. irisin group.
Figure 5 Inhibiting p38 MAPK and ERK prevents the expression of UCP-1. Primary rat (A and C) and 3T3-L1 (B and D) adipocytes were pretreated with SB (10 μmol/L) or U0 (10 μmol/L) and both for 30 min, and then r-irisin (20 nmol/L) was supplemented for an additional 4 days. UCP-1 expression at mRNA level by qPCR analysis (A and B) and at protein levels by Western blotting (C and D) was examined. For C and D, the bar graph represents the ratio of UCP-1/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and is normalized against the control group. Data are expressed as mean ± SE of three independent experiments. *P < 0.05; **P < 0.01 vs. control group; ++P < 0.01; +P < 0.05 vs. irisin group.CC BY-NC-ND · PubMed Central
Figure 6 Binding of irisin to the plasma membrane of 3T3-L1 adipocytes. Confocal microscopy of adipocytes treated with irisin, anti-irisin antibody, and FITC–anti-rabbit IgG antibody (A). Fluorescence microscopy of adipocytes treated with luciferase as control or luciferase-irisin fusion protein (B). The red arrows indicate the cell membrane of the adipocytes bound with irisin fusion protein.
Figure 6 Binding of irisin to the plasma membrane of 3T3-L1 adipocytes. Confocal microscopy of adipocytes treated with irisin, anti-irisin antibody, and FITC–anti-rabbit IgG antibody (A). Fluorescence microscopy of adipocytes treated with luciferase as control or luciferase-irisin fusion protein (B). The red arrows indicate the cell membrane of the adipocytes bound with irisin fusion protein.CC BY-NC-ND · PubMed Central
Figure 7 In vivo effects of r-irisin on body weight and brown-specific gene expression. The mice were intraperitoneally given either r-irisin (0.5 μg/g/day) or saline daily for 14 days and were terminated at day 14 posttreatment. Subcutaneous fat pads were collected and levels of transcripts were analyzed by qPCR for expression of the indicated brown cell–specific genes (A) and betatrophin (B). Representative images from immunohistochemistry against UCP-1 in normal and r-irisin–treated fat mice (C). C57BL/6 mice fed HFD for 10 weeks were intraperitoneally injected with saline or r-irisin, and all analyses were performed at 14 days thereafter (n = 8 for both groups). D: Body weights of mice 14 days after injection with saline or r-irisin (using paired Student t test: control group, P = 0.3196, and irisin-treated group, P = 0.006). E: Intraperitoneal glucose tolerance test. F: Fasting plasma insulin levels measured using radioimmunoassay. Data are expressed as mean ± SE (**P < 0.01; *P < 0.05 vs. control). (A high-quality color representation of this figure is available in the online issue.)
Figure 7 In vivo effects of r-irisin on body weight and brown-specific gene expression. The mice were intraperitoneally given either r-irisin (0.5 μg/g/day) or saline daily for 14 days and were terminated at day 14 posttreatment. Subcutaneous fat pads were collected and levels of transcripts were analyzed by qPCR for expression of the indicated brown cell–specific genes (A) and betatrophin (B). Representative images from immunohistochemistry against UCP-1 in normal and r-irisin–treated fat mice (C). C57BL/6 mice fed HFD for 10 weeks were intraperitoneally injected with saline or r-irisin, and all analyses were performed at 14 days thereafter (n = 8 for both groups). D: Body weights of mice 14 days after injection with saline or r-irisin (using paired Student t test: control group, P = 0.3196, and irisin-treated group, P = 0.006). E: Intraperitoneal glucose tolerance test. F: Fasting plasma insulin levels measured using radioimmunoassay. Data are expressed as mean ± SE (**P < 0.01; *P < 0.05 vs. control). (A high-quality color representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 38 references

Cited by

Items 101–200 of 728

Metadata

Authors
Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., Yang, L.-J., & Tang, D.
Affiliations
  • Shandong University (CN)
  • Second Hospital of Shandong University (CN)
  • University of Florida Health (US)
Corresponding author
  • Cui, Taixing
  • Yang, Li-Jun
  • Tang, Dongqi
Venue
Diabetes
Published
2014-01-16
Volume
63
Issue
2
Pages
514-525
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2121921343
Cited by
733
References
38
Citations by year
2026: 28 · 2025: 49 · 2024: 53 · 2023: 45 · 2022: 80 · 2021: 83 · 2020: 70 · 2019: 48 · 2018: 53 · 2017: 68 · 2016: 55 · 2015: 63 · 2014: 35
FWCI
36.11
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (K01DK080884)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
irisin, white adipose tissue browning, p38 MAPK signaling, ERK signaling, UCP1, betatrophin, glucose homeostasis, obesity, type 2 diabetes, brown adipose tissue thermogenesis
MeSH terms
Mitochondrial Uncoupling Proteins, Animals, Adipose Tissue, Brown, Butadienes, Dietary Fats, Fibronectins, Imidazoles, Male, Mice, Inbred C57BL, Mutation, Nitriles, Pichia, Protein Binding, Pyridines, Recombinant Proteins, Rats, Sprague-Dawley, Adipocytes, MAP Kinase Signaling System, Membrane Transport Proteins, Caenorhabditis elegans Proteins, 3T3-L1 Cells, Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Rats, Adipose Tissue, White

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.